MediWound

About:

MediWound is a biotechnology specialty company focused on developing, manufacturing and commercializing innovative wound care products.

Website: http://mediwound.com

Twitter/X: MediWound

Top Investors: Molnlycke Health Care, U.S. Department of Defense, EIC Accelerator, Point72, Biomedical Advanced Research and Development Authority (BARDA)

Description:

MediWound is a biotechnology niche-specialty company. Established in 2001, MediWound is focused on developing, manufacturing, and globally commercializing innovative products that address unmet needs in the fields of severe burns and chronic wound management. MediWound’s goal is to provide healthcare professionals and patients with its innovative burn wound eschar removal agent, NexoBrid. NexoBrid successfully completed clinical development in hospitalized burn wounds and is approved and ready to launch in Europe.